IRIS
LEONARDI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.872
AS - Asia 3.855
EU - Europa 2.893
SA - Sud America 684
AF - Africa 230
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.704
SG - Singapore 1.083
CN - Cina 1.004
IE - Irlanda 791
HK - Hong Kong 645
BR - Brasile 515
RU - Federazione Russa 463
VN - Vietnam 415
DE - Germania 381
IT - Italia 331
FR - Francia 208
FI - Finlandia 194
IN - India 143
BD - Bangladesh 142
ZA - Sudafrica 142
GB - Regno Unito 116
CA - Canada 85
NL - Olanda 80
AT - Austria 70
MX - Messico 57
AR - Argentina 55
IQ - Iraq 55
JP - Giappone 55
TR - Turchia 44
PL - Polonia 39
SE - Svezia 39
UA - Ucraina 35
PH - Filippine 34
ID - Indonesia 33
ES - Italia 32
PK - Pakistan 29
CO - Colombia 27
AE - Emirati Arabi Uniti 22
SA - Arabia Saudita 22
MA - Marocco 21
VE - Venezuela 21
EC - Ecuador 20
UZ - Uzbekistan 20
BE - Belgio 18
CL - Cile 14
JO - Giordania 14
MY - Malesia 14
PE - Perù 12
LT - Lituania 11
CZ - Repubblica Ceca 10
ET - Etiopia 9
KE - Kenya 9
KZ - Kazakistan 9
MK - Macedonia 9
NP - Nepal 9
RO - Romania 9
TN - Tunisia 9
PA - Panama 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
DZ - Algeria 7
IL - Israele 7
PT - Portogallo 7
AZ - Azerbaigian 6
PY - Paraguay 6
RS - Serbia 6
SN - Senegal 6
TH - Thailandia 6
AU - Australia 5
EG - Egitto 5
KG - Kirghizistan 5
LB - Libano 5
MU - Mauritius 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
CR - Costa Rica 4
GE - Georgia 4
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
KW - Kuwait 3
PS - Palestinian Territory 3
UG - Uganda 3
BH - Bahrain 2
CM - Camerun 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
SR - Suriname 2
SY - Repubblica araba siriana 2
Totale 13.518
Salva come PNG Salva come JPEG
Città #
San Jose 928
Dublin 790
Ashburn 675
Hong Kong 633
Chandler 552
Singapore 512
Dallas 471
Beijing 279
New York 199
Los Angeles 192
Lauterbourg 173
Boardman 164
Ho Chi Minh City 150
Princeton 143
Munich 140
Lawrence 138
Medford 137
Council Bluffs 136
Helsinki 131
Johannesburg 129
Hanoi 113
Wilmington 112
Redondo Beach 74
Moscow 72
Nuremberg 69
Pavia 59
Buffalo 58
Shanghai 57
Milan 50
Orem 49
Santa Clara 49
Tokyo 48
Turku 48
São Paulo 44
Chicago 43
Jacksonville 43
Nanjing 39
Warsaw 38
Falkenstein 35
Montreal 34
Vienna 33
Rio de Janeiro 32
Washington 31
Chennai 30
Brooklyn 28
Norwalk 28
Changsha 25
Haiphong 24
Amsterdam 23
Toronto 23
Atlanta 22
Hangzhou 22
Seattle 22
London 21
The Dalles 21
Baghdad 20
Frankfurt am Main 20
Da Nang 19
Ankara 18
Fairfield 18
Mexico City 18
New Delhi 17
San Francisco 17
Tashkent 17
Woodbridge 17
Brussels 16
Denver 16
Hebei 16
Belo Horizonte 15
Phoenix 15
Poplar 15
Tomsk 15
Guangzhou 14
Redwood City 14
Stockholm 14
Amman 13
Ann Arbor 13
Houston 13
Nanchang 12
Boston 11
Curitiba 11
Dhaka 11
Karachi 11
Manchester 11
Quito 11
Riyadh 11
Hyderabad 10
Mumbai 10
Paris 10
Porto Alegre 10
Rome 10
Tianjin 10
Buenos Aires 9
Caracas 9
Columbus 9
Düsseldorf 9
Jakarta 9
Nairobi 9
Can Tho 8
Dearborn 8
Totale 8.780
Salva come PNG Salva come JPEG
Nome #
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 402
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment 172
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 145
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 143
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 134
Alirocumab and cardiovascular outcomes after acute coronary syndrome 132
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 130
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 128
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 126
Sotagliflozin in patients with diabetes and recent worsening heart failure 124
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 122
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes 122
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 121
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 121
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 120
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 118
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 116
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group 114
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease). 113
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 113
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 112
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 112
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 112
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 110
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 109
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 109
Rivaroxaban with or without aspirin in stable cardiovascular disease 108
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 108
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 106
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 106
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 105
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 104
Utilità della risonanza magnetica cardiaca nella valutazione del profilo emodinamico di pazienti con ipertensione polmonare post-embolica: uno studio di confronto con il cateterismo cardiaco destro. 102
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 102
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study 100
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 99
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention 98
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 97
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 96
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial 95
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial 94
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 94
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 94
Role of cardiac magnetic resonance in the avaluation of the hemodynamic profile of patients with severe chronic thromboembolic pulmonary hypertension: a comparison with right heart catheterization 93
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 92
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 91
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 91
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 90
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 90
Usefulness of cardiac megnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarteriectomy 89
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 89
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement 89
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 88
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 88
The prognostic value of serial troponin measurements in patients admitted for COVID-19 88
Acute Cardiovascular Care 2019 87
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial 87
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 87
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 86
Clinical governance of patients with acute coronary syndromes 84
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 84
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 84
Parenteral antithrombotic therapy during primary percutaneous coronary intervention 83
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease 83
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes 83
Apixaban versus warfarin in patients with atrial fibrillation 82
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 82
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 81
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 80
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY 80
Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study 79
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial 79
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 79
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial 78
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 77
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial 77
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 74
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 74
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization 72
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 72
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function 71
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial 70
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX) 70
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score 70
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 69
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study 69
Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study 67
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data 67
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era 67
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 66
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed 66
[GISE (Italian Society of Interventional Cardiology) Position paper: Short-term hospitalization for percutaneous coronary intervention; a helpful tool to manage post-COVID-19 backlogs] 65
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 65
Around the clock, around the world-reflections on 24 hours of acute cardiovascular care 65
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS 64
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study 64
[Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives] 63
Direct Oral Anticoagulants or Vitamin K Antagonists after TAVR: Insights from the ENVISAGE-TAVI AF and ATLANTIS Trials 63
Rationale and design of the cangrelor versus standard therapy to achieve optimal management of platelet inhibition PHOENIX trial 63
Use of biomarkers to predict specific causes of death in patients with Atrial fibrillation: Insights from the Aristotle Trial 63
Totale 9.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022600 20 33 9 8 10 5 12 35 27 9 88 344
2022/20231.813 233 140 18 91 121 145 3 93 894 15 39 21
2023/2024823 60 170 39 39 74 239 9 64 2 45 31 51
2024/20252.824 80 165 29 55 74 218 225 158 732 143 304 641
2025/20267.115 614 433 753 657 867 230 1.426 382 593 562 373 225
Totale 13.785